Skip to content
value.today

AccuVein Inc.

Formerly Venouslight LLC, AccuVein LLC

Total raised
$59 M
7 rounds on record
Latest round
$17 M
Jul 2020
First round on record
Jul 2011
Today
Private
No later event on record

Funding rounds

7 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of AccuVein Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jul 2020$17 MNo. 7$10 to $50 million

AccuVein Inc.: Raise no. 7, Jul 2020

Investors in this round

36 investors had bought by the notice of Apr 8, 2022: 36 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$17 M of $18 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Christopher Hutchison · Executive Officer, Director
  • Kevin McArdle · Executive Officer
  • Akhilesh Pathipati · Director
  • Brian Verrier · Director
  • Heather Rohan · Director
  • James Lackie · Director
  • Stephen Reeders · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Kevin McArdle, Chief Financial Officer. Source: SEC Form D and 2 amendments, newest notice filed Apr 8, 2022. Read the notice at the SEC.

equitySEC
Apr 2020$3 MNo. 6$2 to $10 million

AccuVein Inc.: Raise no. 6, Apr 2020

Investors in this round

33 investors had bought by the notice of May 12, 2020: 33 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $3 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Chuck Johnson · Executive Officer
  • Ron Goldman · Executive Officer, Director
  • Christopher Gabrieli · Director
  • Hugo Harrod · Director
  • James Lackie · Director
  • Rudy Mazzochi · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Ron Goldman, President and Chief Executive Officer. Source: SEC Form D, newest notice filed May 12, 2020. Read the notice at the SEC.

debt, optionsSEC
Oct 2019$2 MNo. 5$2 to $10 million

AccuVein Inc.: Raise no. 5, Oct 2019

Investors in this round

33 investors had bought by the notice of Nov 15, 2019: 33 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Chuck Johnson · Executive Officer
  • Ron Goldman · Executive Officer, Director
  • Christopher Gabrieli · Director
  • Hugo Harrod · Director
  • James Lackie · Director
  • Rudy Mazzochi · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Ron Goldman, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Nov 15, 2019. Read the notice at the SEC.

debt, optionsSEC
Jan 2018$8 MNo. 4$2 to $10 million

AccuVein Inc.: Raise no. 4, Jan 2018

Investors in this round

40 investors had bought by the notice of Feb 12, 2018: 40 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$8 M of $10 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Ron Goldman · Executive Officer, Director
  • Christopher Gabrieli · Director
  • Hugo Harrod · Director
  • James Lackie · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Ron Goldman, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Feb 12, 2018. Read the notice at the SEC.

equitySEC
Sep 2017$3 MNo. 3$2 to $10 million

AccuVein Inc.: Raise no. 3, Sep 2017

Investors in this round

11 investors had bought by the notice of Jan 2, 2018: 11 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $3 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Ron Goldman · Executive Officer, Director
  • Christopher Gabrieli · Director
  • Frank Flaunt III · Director
  • Hugo Harrod · Director
  • James Lackie · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Amounts invested in three (3) closings.”

Signed by Ron Goldman, President and Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Jan 2, 2018. Read the notice at the SEC.

debt, optionsSEC
Nov 2016$2 MNo. 2$2 to $10 million

AccuVein Inc.: Raise no. 2, Nov 2016

Investors in this round

28 investors had bought by the notice of Dec 2, 2016: 28 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $9 M offered; $7 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Ron Goldman · Executive Officer, Director
  • Christopher Gabrieli · Director
  • Eric Bednarski · Director
  • Frank Flaut III · Director
  • James Lackie · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Ron Goldman, President and CEO. Source: SEC Form D, newest notice filed Dec 2, 2016. Read the notice at the SEC.

debt, optionsSEC
Jul 2011$23 MNo. 1$10 to $50 million

AccuVein Inc.: Raise no. 1, Jul 2011

Investors in this round

62 investors had bought by the notice of Oct 27, 2011: 62 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$23 M of $23 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$1,560,000
Finders' fees
none
Paid to its own people
$423,117 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions and payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Joseph Anthony McCormick · Executive Officer
  • Joseph Anthony Zott · Executive Officer
  • Ron Goldman · Executive Officer, Director
  • Vincent Anthony Luciano · Executive Officer
  • Christopher Anthony Gabrieli · Director
  • Eric Anthony Bednarski · Director
  • Frank Lee Flautt III · Director
  • James Donald Lackie · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Aquilo Partners, L.P. (CRD 114909) · San Francisco, CaliforniaSold in CA, CT, IL, MA, NY, OH, PA, TX, UT, WA

Remarks in the notice

  • On the use of proceeds: “Repayment of loans made by two directors and one officer”

Signed by Ron Goldman, Ceo. Source: SEC Form D and 1 amendment, newest notice filed Oct 27, 2011. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • AccuVein Inc. chose not to state its revenue in its newest notice of a funding round (Apr 2022).

    SEC Form D · Apr 2022

  • The industry group it chose in its notices: Manufacturing.

    SEC Form D · Apr 2022

That is all the official record says: AccuVein Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of AccuVein Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 7 rounds above had up to 62 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by AccuVein Inc.
NameRoleNamed in
Christopher HutchisonExecutive officerApr 2022
Kevin McArdleExecutive officerApr 2022
Chuck JohnsonExecutive officerMay 2020
Ron GoldmanExecutive officerMay 2020
Joseph Anthony McCormickExecutive officerOct 2011
Joseph Anthony ZottExecutive officerOct 2011
Vincent Anthony LucianoExecutive officerOct 2011
Akhilesh PathipatiDirectorApr 2022
Brian VerrierDirectorApr 2022
Christopher HutchisonDirectorApr 2022
Heather RohanDirectorApr 2022
James LackieDirectorApr 2022
Stephen ReedersDirectorApr 2022
Hugo HarrodDirectorOct 2020
Rudy MazzochiDirectorOct 2020
Christopher GabrieliDirectorMay 2020
Ron GoldmanDirectorMay 2020
Frank Flaunt IIIDirectorJan 2018
Eric BednarskiDirectorDec 2016
Frank Flaut IIIDirectorDec 2016
Christopher Anthony GabrieliDirectorOct 2011
Eric Anthony BednarskiDirectorOct 2011
Frank Lee Flautt IIIDirectorOct 2011
James Donald LackieDirectorOct 2011